Parkinson’s disease patients treated with levodopa exhibit a different pattern in the expression of emerging cytokines, IL-35 subunit and IL-37, compared to control group: A statistical analysis using Bayesian regression model

Abstract excerpt

<title>Abstract</title> <p>Background Parkinson's disease (PD), is known as one of the most common neurodegenerative diseases in the world, which is characterized by the destruction of dopaminergic neurons in the substantia nigra of the midbrain. In the pathogenesis of this disease, central and peripheral inflammation play important roles. This study was done to investigate the expression of IL-35 (including P35...

Topics

Open a Topic to create a Post that cites this publication.

• Electrospun Nanofibers in Biomedical Applications
• MicroRNA in disease regulation
• Neuroinflammation and Neurodegeneration Mechanisms
• Neurological disorders and treatments
• NF-κB Signaling Pathways
• Nuclear Receptors and Signaling
• Parkinson's Disease Mechanisms and Treatments
• RNA regulation and disease

Identifiers and source

Literature Corpus work

d572a03a-bdb9-5768-bcaa-3d66d87ede99

DOI

10.21203/rs.3.rs-5666330/v1